Jill Wechsler is Pharm Exec's Washington Corespondent

Jill Wechsler, Pharm Exec's Washington Correspondent

Articles

This week's much-anticipated meeting of FDA’s vaccine advisory committee will address critical issues related to the testing and approval of vaccines to prevent COVID-19 infection.

Early Vaccine Authorization Raises Ethical & Logistical Challenges for Trial Sponsors

Missteps threaten agency’s independence as vaccines seek finish line.

FDA Struggles to Retain Credibility

FDA has published updated Emergency Use Authorization (EUA) requirements for new coronavirus preventives.

Industry Backs Clear FDA Standards for COVID Vaccine Authorization

Experts fear confusion over allocation process, cold-chain requirements, IT systems.





Author | Jill Wechsler, Pharm Exec's Washington Correspondent

Articles

Early Vaccine Authorization Raises Ethical & Logistical Challenges for Trial Sponsors

FDA Struggles to Retain Credibility

Industry Backs Clear FDA Standards for COVID Vaccine Authorization

COVID Vaccine Distribution Raises Multiple Challenges